Answer
Rivaroxaban (Xarelto) is contraindicated during pregnancy because of potential reproductive toxicity demonstrated in animal studies, its intrinsic bleeding risk and evidence that it crosses the placenta, while safety and efficacy in pregnant women have not been established.
Sources for this answer
- Xarelto 10 mg film-coated tabletsBayer plc · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 36Document updated
Sources checked